Dkk3-flox Mouse
一般名
Dkk3-flox
製品ID
S-CKO-11394
背景情報
C57BL/6NCya
系統ID
CKOCMP-50781-Dkk3-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Dkk3-flox Mouse(カタログ番号S-CKO-11394)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Dkk3-flox
系統ID
CKOCMP-50781-Dkk3-B6N-VA
遺伝子名
製品ID
S-CKO-11394
遺伝子別名
dkk-3, mDkk-3
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conditional knockout
染色体
Chr 7
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000033036
NCBIトランスクリプトID
NM_015814
ターゲット領域
Exon 5~6
有効領域の大きさ
~1.8 kb
遺伝子研究の概要
Dkk3, belonging to the DKK family, codes for an evolutionally conserved secreted glycoprotein. It functions as an antagonist of the oncogenic Wnt signaling pathway and has been implicated in multiple biological processes and diseases [3,6,7]. Genetic models like KO/CKO mouse models are valuable for studying its functions.
In muscle-related studies, myofiber-specific ablation of Baf60c in mice led to a robust upregulation of Dkk3, which inhibited muscle stem cell differentiation and attenuated muscle regeneration in vivo. Conversely, Dkk3 blockade promoted muscle regeneration and contraction, indicating Dkk3's role in muscle regeneration through paracrine signaling [1].
In renal fibrosis, knockdown of Dkk3 in UUO mice inhibited oxidative stress, maintained mitochondrial homeostasis, and alleviated kidney damage and fibrosis. Mechanistically, Dkk3 activated the Wnt/β -catenin pathway to increase MFF transcriptional expression, leading to mitochondrial dysfunction [2].
In head and neck squamous cell carcinoma (HNSCC), Dkk3 knockdown significantly decreased cell proliferation, migration, and invasion through decreased AKT phosphorylation, suggesting its oncogenic function in HNSCC [3].
In neuropathic pain, exogenous intrathecal administration of rDKK3 inhibited microglial activation-related signaling, promoted microglia transformation from M1 to M2 type, and decreased pro-inflammatory cytokines, ameliorating neuropathic pain [4].
In chronic obstructive pulmonary disease (COPD)-related sarcopenia, Dkk3 was overexpressed, and its inhibition prevented cigarette-smoking-induced skeletal muscle dysfunction, suggesting it as a potential diagnostic and therapeutic target [5].
In children with chronic kidney disease, urinary DKK3 above the median was associated with a greater 6-month eGFR decline, and it could help identify those who benefit from pharmacological nephroprotection [8].
In conclusion, Dkk3 plays diverse roles in multiple biological processes and disease conditions. Mouse models with Dkk3 knockout or knockdown have revealed its functions in muscle regeneration, renal fibrosis, cancer, neuropathic pain, sarcopenia in COPD, and kidney function decline in children. These findings contribute to understanding disease mechanisms and potentially developing new therapeutic strategies.
References:
1. Xu, Jingya, Li, Xiaofei, Chen, Wei, Shan, Pengfei, Meng, Zhuo-Xian. 2023. Myofiber Baf60c controls muscle regeneration by modulating Dkk3-mediated paracrine signaling. In The Journal of experimental medicine, 220, . doi:10.1084/jem.20221123. https://pubmed.ncbi.nlm.nih.gov/37284884/
2. Song, Jianling, Chen, Yanxia, Chen, Yan, Ke, Ben, Fang, Xiangdong. 2024. DKK3 promotes renal fibrosis by increasing MFF-mediated mitochondrial dysfunction in Wnt/β-catenin pathway-dependent manner. In Renal failure, 46, 2343817. doi:10.1080/0886022X.2024.2343817. https://pubmed.ncbi.nlm.nih.gov/38682264/
3. Katase, Naoki, Nagano, Kenichi, Fujita, Shuichi. 2020. DKK3 expression and function in head and neck squamous cell carcinoma and other cancers. In Journal of oral biosciences, 62, 9-15. doi:10.1016/j.job.2020.01.008. https://pubmed.ncbi.nlm.nih.gov/32032750/
4. Zhang, Long-Qing, Gao, Shao-Jie, Sun, Jia, Zhou, Ya-Qun, Mei, Wei. 2022. DKK3 ameliorates neuropathic pain via inhibiting ASK-1/JNK/p-38-mediated microglia polarization and neuroinflammation. In Journal of neuroinflammation, 19, 129. doi:10.1186/s12974-022-02495-x. https://pubmed.ncbi.nlm.nih.gov/35658977/
5. Wang, Zilin, Deng, Mingming, Xu, Weidong, Zhou, Xiaoming, Hou, Gang. 2024. DKK3 as a diagnostic marker and potential therapeutic target for sarcopenia in chronic obstructive pulmonary disease. In Redox biology, 78, 103434. doi:10.1016/j.redox.2024.103434. https://pubmed.ncbi.nlm.nih.gov/39571512/
6. Hamzehzadeh, Leila, Caraglia, Michele, Atkin, Stephen L, Sahebkar, Amirhossein. 2018. Dickkopf homolog 3 (DKK3): A candidate for detection and treatment of cancers? In Journal of cellular physiology, 233, 4595-4605. doi:10.1002/jcp.26313. https://pubmed.ncbi.nlm.nih.gov/29206297/
7. Xia, Zhiliang, Du, Dan, Zhang, Zhi, Guo, Xiong, He, Ziqiu. 2024. WIF1 and DKK3 in prostate cancer: from molecular pathways to therapeutic targets: a narrative review. In Translational andrology and urology, 13, 2601-2616. doi:10.21037/tau-24-304. https://pubmed.ncbi.nlm.nih.gov/39698576/
8. Speer, Thimoteus, Schunk, Stefan J, Sarakpi, Tamim, Fliser, Danilo, Schaefer, Franz. 2023. Urinary DKK3 as a biomarker for short-term kidney function decline in children with chronic kidney disease: an observational cohort study. In The Lancet. Child & adolescent health, 7, 405-414. doi:10.1016/S2352-4642(23)00049-4. https://pubmed.ncbi.nlm.nih.gov/37119829/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
